TTK HEALTHCARE
|
TTK HEALTHCARE Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 31.61 | 13.10 | 26.03 | 8.72 | 17.25 |
| CEPS(Rs) | 40.67 | 22.01 | 35.24 | 18.89 | 27.63 |
| DPS(Rs) | 10.00 | 10.00 | 6.00 | 3.00 | 5.00 |
| Book NAV/Share(Rs) | 671.59 | 230.16 | 205.40 | 173.09 | 174.81 |
| Tax Rate(%) | 27.53 | 25.47 | -62.60 | 36.58 | 37.92 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 4.32 | 3.64 | 4.06 | 4.38 | 7.89 |
| EBIT Margin(%) | 9.22 | 4.69 | 5.11 | 3.51 | 6.79 |
| Pre Tax Margin(%) | 8.50 | 4.14 | 4.75 | 3.01 | 6.25 |
| PAT Margin (%) | 6.16 | 3.09 | 7.73 | 1.91 | 3.88 |
| Cash Profit Margin (%) | 7.93 | 5.19 | 10.46 | 4.13 | 6.22 |
| Performance Ratios | |||||
| ROA(%) | 5.20 | 3.56 | 8.04 | 2.94 | 5.99 |
| ROE(%) | 7.01 | 6.02 | 13.76 | 5.01 | 10.25 |
| ROCE(%) | 10.13 | 8.59 | 8.38 | 8.28 | 15.46 |
| Asset Turnover(x) | 0.84 | 1.15 | 1.04 | 1.54 | 1.54 |
| Sales/Fixed Asset(x) | 4.41 | 3.70 | 3.10 | 4.41 | 4.40 |
| Working Capital/Sales(x) | 0.85 | 2.66 | 2.55 | 5.10 | 5.48 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.23 | 0.27 | 0.32 | 0.23 | 0.23 |
| Receivable days | 36.67 | 34.52 | 52.35 | 44.37 | 39.41 |
| Inventory Days | 41.14 | 45.45 | 54.42 | 35.88 | 31.45 |
| Payable days | 119.60 | 130.35 | 160.52 | 111.76 | 110.54 |
| Valuation Parameters | |||||
| PER(x) | 32.71 | 63.29 | 19.00 | 37.50 | 39.34 |
| PCE(x) | 25.42 | 37.68 | 14.03 | 17.31 | 24.56 |
| Price/Book(x) | 1.54 | 3.60 | 2.41 | 1.89 | 3.88 |
| Yield(%) | 0.97 | 1.21 | 1.21 | 0.92 | 0.74 |
| EV/Net Sales(x) | 0.88 | 1.53 | 1.03 | 0.55 | 1.37 |
| EV/Core EBITDA(x) | 8.03 | 24.06 | 16.71 | 9.66 | 15.04 |
| EV/EBIT(x) | 9.56 | 32.71 | 20.09 | 15.78 | 20.21 |
| EV/CE(x) | 0.55 | 1.67 | 1.00 | 0.84 | 2.10 |
| M Cap / Sales | 2.01 | 1.96 | 1.47 | 0.72 | 1.53 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 21.01 | 25.88 | -26.28 | 2.85 | 8.72 |
| Core EBITDA Growth(%) | 108.76 | 30.47 | -21.08 | -35.31 | 14.34 |
| EBIT Growth(%) | 138.20 | 15.38 | 7.22 | -46.78 | 22.26 |
| PAT Growth(%) | 141.32 | -49.68 | 198.57 | -49.46 | 34.18 |
| EPS Growth(%) | 141.31 | -49.68 | 198.57 | -49.46 | 34.18 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.03 | 0.06 | 0.06 | 0.12 | 0.12 |
| Current Ratio(x) | 5.06 | 2.13 | 1.99 | 1.74 | 1.73 |
| Quick Ratio(x) | 4.66 | 1.74 | 1.62 | 1.32 | 1.38 |
| Interest Cover(x) | 12.76 | 8.67 | 14.22 | 6.94 | 12.62 |
| Total Debt/Mcap(x) | 0.02 | 0.02 | 0.03 | 0.06 | 0.03 |
Compare Financial Ratios of peers of TTK HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TTK HEALTHCARE | ₹2,150.3 Cr | -0.1% | -1% | 71.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹369,402.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
| CIPLA | ₹109,341.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,341.0 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹99,176.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹96,543.1 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
TTK HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TTK HEALTHCARE | -0.1% |
-1% |
71.4% |
| SENSEX | -0.8% |
1.4% |
22.9% |
You may also like the below Video Courses
